"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Barclays raised the firm’s price target on Abbott (ABT) to $158 from $149 and keeps an Overweight rating on the shares. The firm increased ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...

Abbott Laboratories closed 3.99% below its 52-week high of $121.64, which the company reached on March 8th.

Abbott Elementary, starring Quinta Brunson, has been renewed for Season 5, the first ABC series to secure its spot on the ...

Welcome to Abbott's Fourth Quarter 2024 Earnings Conference Call. (Operator Instructions) This call is being recorded by Abbott. With the exception of any participant's questions asked during the ...

Jan 22 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.